The effect of anemia on the efficacy and safety of treating chronic hepatitis C infection with direct-acting antivirals in patients with chronic kidney disease

被引:0
|
作者
Ahmed Yahia Elmowafy
Mohamed Hamed Abbas
Ahmed Abdelfattah Denewar
Mohamed Elsayed Mashaly
Gamal Shiha
Salwa Mahmoud El Wasif
Lionel Rostaing
Mohamed Adel Bakr
机构
[1] Mansoura University,Urology and Nephrology Center
[2] Egyptian Liver Research Institute and Hospital,Service de Néphrologie, Hémodialyse, Aphérèses et Transplantation Rénale
[3] Université Grenoble Alpes,undefined
[4] CHU Grenoble-Alpes,undefined
来源
关键词
Chronic kidney disease; HCV infection; Sofosbuvir; Daclatasvir; Anemia; Kidney transplantation; Hemodialysis; DAA therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:749 / 761
页数:12
相关论文
共 50 条
  • [31] Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5
    Chen-Hua Liu
    Jia-Horng Kao
    Hepatology International, 2022, 16 : 1001 - 1019
  • [32] Efficacy and safety of new direct-acting antivirals in kidney transplant recipients with chronic hepatitis C: a single-center study
    Darema, Maria
    Cholongitas, Evangelos
    Filiopoulos, Vassilis
    Marinaki, Smaragdi
    Pavlopoulou, Ioanna D.
    Tsoubou, Ioanna
    Boletis, John N.
    Papatheodoridis, George, V
    ANNALS OF GASTROENTEROLOGY, 2020, 33 (03): : 285 - 292
  • [33] Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5
    Liu, Chen-Hua
    Kao, Jia-Horng
    HEPATOLOGY INTERNATIONAL, 2022, 16 (05) : 1001 - 1019
  • [34] Efficacy and Safety Profile of Direct-Acting Antiviral Agents in Hemodialysis Patients With Chronic Hepatitis C Infection
    Hanif, Farina
    Luck, Nasir
    Mandhwani, Rajesh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S557 - S558
  • [35] Cost-effectiveness of Treating Acute versus Chronic Hepatitis C Infection Using Direct-Acting Antivirals
    Bethea, Emily D.
    Chen, Qiushi
    Hur, Chin
    Chung, Raymond T.
    Chhatwal, Jagpreet
    HEPATOLOGY, 2017, 66 : 10A - 10A
  • [36] Chronic Hepatitis C in Elderly Patients: Current Evidence with Direct-Acting Antivirals
    Manan A. Jhaveri
    Vignan Manne
    Kris V. Kowdley
    Drugs & Aging, 2018, 35 : 117 - 122
  • [37] Electrophysiological Adverse Effects of Direct-Acting Antivirals in Patients With Chronic Hepatitis C
    Rossotti, Roberto
    Fraile, Lucio Jesus Garcia-Fraile
    Baiguera, Chiara
    Puoti, Massimo
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (07): : 931 - 932
  • [38] Simple predictors of nonresponse to direct-acting antivirals in chronic hepatitis C patients
    Shousha, Hend Ibrahim
    Saad, Yasmin
    Saleh, Doa'a A.
    Dabes, Hosam
    Alserafy, Magdy
    ElShazly, Yehia
    Said, Mohamed
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (08) : 1017 - 1022
  • [39] Chronic Hepatitis C in Elderly Patients: Current Evidence with Direct-Acting Antivirals
    Jhaveri, Manan A.
    Manne, Vignan
    Kowdley, Kris V.
    DRUGS & AGING, 2018, 35 (02) : 117 - 122
  • [40] Evaluation of fibrosis in chronic hepatitis C patients treated with direct-acting antivirals
    Tufan, Ayse Gokcen
    Hakim, Gozde Dervis
    Akar, Harun
    Akarsu, Mesut
    HEPATOLOGY FORUM, 2020, 1 (02): : 53 - 58